J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adjou, K. T.
Right arrow Articles by Dormont, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adjou, K. T.
Right arrow Articles by Dormont, D.
Agricola
Right arrow Articles by Adjou, K. T.
Right arrow Articles by Dormont, D.

Journal of General Virology, Vol 80, 1079-1085, Copyright © 1999 by Society for General Microbiology

ARTICLES

MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie

KT Adjou, R Demaimay, JP Deslys, CI Lasmezas, V Beringue, S Demart, F Lamoury, M Seman and D Dormont
CEA, Service de Neurovirologie, Fontenay aux Roses, France. ADJOU@dsvidf.cea.fr

Amphotericin B (AmB) has been shown to delay hamster scrapie. Infectivity studies have been performed previously using AmB in order to understand the relationship between the accumulation of an abnormal isoform (PrPres) of the prion protein and 263K scrapie agent replication in the brain. The first study reported that AmB had no effect upon agent replication, although it delayed the development of both clinical signs and PrPres accumulation. However, subsequent experiments using the same model showed a significant effect both on agent replication and PrPres accumulation early in infection. This fundamental discrepancy was assumed to be linked to differences in experimental protocols. In order to unravel the issue, a new experiment has been performed encompassing different protocols and using an AmB derivative, MS-8209, that can be used at higher doses because of its lower toxicity. The findings of this study exclude the suspected differences in the protocols as the reason for previous conflicting results, and suggest strongly that these discrepancies were due to a low dose of AmB causing a 'threshold effect'. Overall, this study indicates that, in this model, PrPres cannot be dissociated from infectivity by polyene antibiotics.


This article has been cited by other articles:


Home page
 J. Virol.Home page
M. Prior, S. Lehmann, M.-S. Sy, B. Molloy, and H. E. M. McMahon
Cyclodextrins Inhibit Replication of Scrapie Prion Protein in Cell Culture
J. Virol., October 15, 2007; 81(20): 11195 - 11207.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. R Trevitt and J. Collinge
A systematic review of prion therapeutics in experimental models
Brain, September 1, 2006; 129(9): 2241 - 2265.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Nunziante, C. Kehler, E. Maas, M. U. Kassack, M. Groschup, and H. M. Schatzl
Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication
J. Cell Sci., November 1, 2005; 118(21): 4959 - 4973.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Supattapone, H. Wille, L. Uyechi, J. Safar, P. Tremblay, F. C. Szoka, F. E. Cohen, S. B. Prusiner, and M. R. Scott
Branched Polyamines Cure Prion-Infected Neuroblastoma Cells
J. Virol., April 1, 2001; 75(7): 3453 - 3461.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.